Subject "4.20.03 Drug addiction, alcoholism, smoking"
subscribeDossiers (51)
Evaluation of the EU Drugs Strategy 2013-2020 and the EU Action Plan on Drugs 2017-2020. Executive summary
Evaluation of the EU Drugs Strategy 2013-2020 and the EU Action Plan on Drugs 2017-2020
Single Convention on Narcotic Drugs (1961), as amended by the 1972 Protocol, and the Convention on Psychotropic Substances (1971): scheduling of substances. EU position
EU Agenda and Action Plan on Drugs 2021-2025
Single Convention on Narcotic Drugs (1961), as amended by the 1972 Protocol, and the Convention on Psychotropic Substances (1971): scheduling of substances. EU position
Single Convention on Narcotic Drugs (1961), as amended by the 1972 Protocol, and the Convention on Psychotropic Substances (1971): scheduling of substances. EU position
European citizens’ initiative: ‘European Cannabis Initiative’. Commission Implementing Decision
European Union Drugs Agency
Inclusion of the new psychoactive substances methyl 3,3-dimethyl-2-{[1-(pent-4-en-1-yl)-1H-indazole-3-carbonyl]amino}butanoate (MDMB-4en-PINACA) and methyl 2-{[1-(4-fluorobutyl)-1H-indole-3-carbonyl]amino}-3,3-dimethylbutanoate (4F-MDMB-BICA) in the definition of ‘drug’
Inclusion of the new psychoactive substance N,N-diethyl-2-[[4-(1-methylethoxy)phenyl]methyl]-5-nitro-1H-benzimidazole-1-ethanamine (isotonitazene) in the definition of 'drug' (amend. the Annex to Council Framework Decision 2004/757/JHA)
Resolution on use of cannabis for medicinal purposes
Data storage contracts to be concluded as part of a traceability system for tobacco products
Subjecting the new psychoactive substance N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]furan-2-carboxamide (furanylfentanyl) to control measures
Subjecting N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide (acryloylfentanyl) to control measures
Subjecting the new psychoactive substance methyl 2-[[1-(cyclohexylmethyl)-1Hindole-3-carbonyl]amino]-3,3-dimethylbutanoate (MDMB-CHMICA) to control measures
Resolution on the alcohol strategy
Subjecting the new psychoactive substance 1-phenyl-2-(pyrrolidin-1-yl)pentan-1-one (α-pyrrolidinovalerophenone, α-PVP) to control measures
Library of picture warnings to be used on tobacco products
New psychoactive substances
Minimum provisions on the constituent elements of criminal acts and penalties in the field of illicit drug trafficking: definition of 'drug'
EU/Croatia agreement: participation of Croatia in the work of the European Monitoring Centre for Drugs and Drug Addiction
Resolution on smoke-free environments
Public health: smoke-free environments
Green Paper on the role of civil society in drugs policy in the EU
Green Paper 'Towards a Europe free from tobacco smoke: policy options at EU level'
EU strategy to support Member States in reducing alcohol related harm
Agreement EC/Bulgaria: participation in the work of the European Monitoring Centre for Drugs and Drug Addiction
Agreement EC/Turkey: participation in the work of the European Monitoring Centre for Drugs and Drug Addiction EMCDDA
EC/Romania agreement: participation in the work of the European Monitoring Centre for Drugs and Drug Addiction
EC/Norway agreement: European Monitoring Centre for Drugs and Drug Addiction EMCDDA, revision of the amount of the financial contribution
Implications of the agreement between the Community, Member States and Philip Morris on intensifying the fight against fraud and cigarette smuggling and progress made in implementing the recommendations of Parliament's Committee of Inquiry into the Community Transit System
European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). Recast
European Monitoring Centre for Drugs and Drug Addiction: Director's term of office
General programme "Fundamental Rights and Justice": specific programme "Drugs prevention and information", 2007-2013
Reform of the Conventions on drugs
World Health Organisation (WHO) Framework Convention on Tobacco Control
Public health: prevention of smoking and initiatives to improve tobacco control
Public health: Union strategy on drugs 2000-2004, prevention and reduction of risks of drug dependence
Resolution on the Union's position on the World Health Organisation WHO Framework Convention on Tobacco Control
Public health: drinking of alcohol by children and adolescents. Recommendation
Advertising and sponsorship of tobacco products
Action to combat drugs: action plan 2000-2004
Tobacco: manufacture, presentation and sale of products (recast of Directives 89/622/EEC, 92/41/EEC, 90/239/EEC)
EC/Norway agreement: participation in the work of the European Monitoring Centre for Drugs and Drug Addiction EMCDDA
European monitoring centre for drugs and addiction EMCDDA: assistance to applicant countries (amend. Regulation (EEC) No 302/93)
European Monitoring Centre for Drugs and Drug Addiction EMCDDA: drugs in the Union. Annual report 1997
Combating tobacco consumption: Community role
Taxes other than turnover taxes which affect the consumption of manufactured tobacco
Public health: Community action programme 1996-2000 on the prevention of drug dependence
Decentralized Community agencies: establishment of the European Monitoring Centre for Drugs and Drug Addiction EMCDDA (amend. Regul. 302/93/EEC)
Tobacco products: advertising and sponsorship by press, radio, television
Subscribe